RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Purpose: Bilateral breast cancer (BBC) can be divided into two concurrent lesions, depending on the time of occurrence of primary cancer and secondary tumors after treatment of the primary cancer. This study aimed to compare the clinicopathological characteristics and results of synchronous BBC (SBBC) and metachronous BBC (MBBC).Methods: Data of patients diagnosed with breast cancer at Wonkwang university Hospital between October 1991 and October 2021 were retrospectively reviewed. Data of 3,259 patients who were diagnosed with malignant neoplasm of the right or left breast were reviewed. The tumor was defined as SBBC when another cancer was identified as BBC simultaneously or within six months after the primary breast cancer, and as MBBC when another cancer was identified after six months. Among patients with BBC, 31 had SBBC and 32 had MBBC.Results: In SBBC patients, the median age was 59.9 years, and the condition was diagnosed 3.3 years later compared with MBBC. The primary and secondary tumors of SBBC had lower disease stage, even when diagnosed late. Except for tumor, node, and metastasis stage, MBBC showed more invasive ductal carcinoma, while SBBC showed relatively more ductal carcinoma <i>in situ</i> in both primary and secondary tumors compared with MBBC. In addition, SBBC showed lower hormone receptor positivity rates and Ki-67 levels compared with MBBC. MBBC patients showed a higher survival rate compared with SBBC patients. MBBC is associated with higher overall survival rate compared with SBBC, and its prognosis is not worse compared with that of unilateral breast cancer. In the case of secondary tumor that develops in the contralateral breast without evidence of metastasis, the survival rate is similar to that of unilateral breast cancer, while the treatment is similar to that of primary tumor.Conclusion: As those with SBBC have a worse survival, these patients will require more medical attention; meanwhile, MBBC requires an active treatment approach that is equivalent to that for unilateral breast cancer.

번역하기

참고문헌 (Reference)

1 Shen K, "Worse characteristics can predict survival effectively in bilateral primary breast cancer : a competing risk nomogram using the SEER database" 8 : 7890-7902, 2019

2 Vichapat V, "Tumor stage affects risk and prognosis of contralateral breast cancer : results from a large Swedish-population-based study" 30 : 3478-3485, 2012

3 Rhiem K, "The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families : a retrospective cohort study" 14 : R156-, 2012

4 Kilgore AR, "The incidence of cancer in the second breast : after radical removal of one breast for cancer" 77 : 454-457, 1921

5 Bland KI, "The breast: comprehensive management of benign and malignant diseases" Elsevier 967.e2-973.e2, 2018

6 Jobsen JJ, "Synchronous bilateral breast cancer : prognostic value and incidence" 12 : 83-88, 2003

7 Hislop TG, "Second primary cancers of the breast : incidence and risk factors" 49 : 79-85, 1984

8 Abo-Madyan Y, "Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer" 110 : 471-476, 2014

9 Horn PL, "Risk of contralateral breast cancer. Associations with histologic, clinical, and therapeutic factors" 62 : 412-424, 1988

10 Bernstein JL, "Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer" 136 : 925-936, 1992